The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 1, 2026
Protean Select operates as a versatile long/short equity hedge fund designed to exploit both structural long-term free cash flow compounders and opportunistic short-term market dislocations. In September 2026, the fund gained 0.8% net of fees, maintaining average beta-adjusted net exposure at 35% before entering October at 29% net exposure and 133% gross exposure. Performance during the month was driven positively by long holdings in Yubico, Axfood, and Beijer Ref, alongside short positions in Essity and Novo Nordisk, while key detractors included Devyser, DSV, Fortum, and RVRC. Portfolio positioning reflects a balanced long/short energy framework, including an active 3% position in Neste to capitalize on European diesel refining tightness, as well as tactical exposures to a recovering Nordic consumer via holdings such as Lindex, Storskogen, and RVRC. The management framework emphasizes strict risk control and capital preservation, deliberately sizing positions down when volatility escalates or theses evolve.
True investing edge stems from owning durable, underpriced free cash flow streams while strictly controlling downside volatility and tactically trading short-term market dislocations.
The manager expects short-term equity markets to remain characterized by noise, passive index distortions, and factor volatility, while maintaining confidence that business free cash flows will ultimately govern long-term performance. In Protean Select, the strategy emphasizes selective exposure to unappreciated domestic cyclical recoveries and tactical seasonal dislocations, backed by low net exposures and disciplined stop-loss rules.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Protean Select or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.